Can complete blood count inflammatory parameters in epithelial ovarian cancer contribute to prognosis? - a survival analysis

Abstract Subjective The aim of the present study was to investigate the prognostic significance of preoperative complete blood count inflammatory markers in women operated for invasive Epithelial Ovarian Cancer (EOC). Method Two hundred forty four patients that underwent operation with the diagnosis...

Full description

Bibliographic Details
Main Authors: Mehmet Ufuk Ceran, Umit Tasdemir, Eser Colak, Tayfun Güngör
Format: Article
Language:English
Published: BMC 2019-02-01
Series:Journal of Ovarian Research
Subjects:
PLR
NLR
Online Access:http://link.springer.com/article/10.1186/s13048-019-0491-7
id doaj-8d01fc12b2df444ba78a09de92192a9b
record_format Article
spelling doaj-8d01fc12b2df444ba78a09de92192a9b2020-11-25T01:01:14ZengBMCJournal of Ovarian Research1757-22152019-02-011211710.1186/s13048-019-0491-7Can complete blood count inflammatory parameters in epithelial ovarian cancer contribute to prognosis? - a survival analysisMehmet Ufuk Ceran0Umit Tasdemir1Eser Colak2Tayfun Güngör3Department of Gynecology and Obstetrics, Baskent University School of Medicine, Konya Medical and Research CenterDepartment of Gynecology and Obstetrics, Baskent University School of Medicine, Konya Medical and Research CenterDepartment of Gynecology and Obstetrics, Baskent University School of Medicine, Konya Medical and Research CenterDepartment of Gynecologic Oncology, Zekai Tahir Burak Women’s Health, Education and Research HospitalAbstract Subjective The aim of the present study was to investigate the prognostic significance of preoperative complete blood count inflammatory markers in women operated for invasive Epithelial Ovarian Cancer (EOC). Method Two hundred forty four patients that underwent operation with the diagnosis of invasive EOC between 2006 and 2014 were included in the study. The date of operation, date of recurrence and final mortality evaluations were performed for survival analysis. The sensitivity, specificity, PPV and NPV were separately calculated with ROC analysis. Survival analysis was carried out with Kaplan Meier-Log Rank Method. Results Five-years overall survival rate was 56, 9% and 5-year disease-free survival (DFS) rate was 45,5%. Advanced disease stage, moderate-poor tumor differentiation, and the presence of recurrence were determined to have significant inverse relation at mean survival and 5-year survival rates. Neutrophil/lymphocyte ratio (NLR) and Platelet lymphocyte ratio (PLR) had prognostic effect on both DFS and overall survival based upon the cut-off values determined in the study (PLR = 231, s36, NLR = 3,83). Histopathological subtypes were not found to have any prognostic value. In correlation analysis, PLR and NLR had positive correlation with each other and negative correlation with overall survival. Conclusions Inflammatory markers such as NLR and PLR have independent prognostic value for women who undergo surgery for invasive EOC.http://link.springer.com/article/10.1186/s13048-019-0491-7Epithelial ovarian cancerSurvivalPLRNLR
collection DOAJ
language English
format Article
sources DOAJ
author Mehmet Ufuk Ceran
Umit Tasdemir
Eser Colak
Tayfun Güngör
spellingShingle Mehmet Ufuk Ceran
Umit Tasdemir
Eser Colak
Tayfun Güngör
Can complete blood count inflammatory parameters in epithelial ovarian cancer contribute to prognosis? - a survival analysis
Journal of Ovarian Research
Epithelial ovarian cancer
Survival
PLR
NLR
author_facet Mehmet Ufuk Ceran
Umit Tasdemir
Eser Colak
Tayfun Güngör
author_sort Mehmet Ufuk Ceran
title Can complete blood count inflammatory parameters in epithelial ovarian cancer contribute to prognosis? - a survival analysis
title_short Can complete blood count inflammatory parameters in epithelial ovarian cancer contribute to prognosis? - a survival analysis
title_full Can complete blood count inflammatory parameters in epithelial ovarian cancer contribute to prognosis? - a survival analysis
title_fullStr Can complete blood count inflammatory parameters in epithelial ovarian cancer contribute to prognosis? - a survival analysis
title_full_unstemmed Can complete blood count inflammatory parameters in epithelial ovarian cancer contribute to prognosis? - a survival analysis
title_sort can complete blood count inflammatory parameters in epithelial ovarian cancer contribute to prognosis? - a survival analysis
publisher BMC
series Journal of Ovarian Research
issn 1757-2215
publishDate 2019-02-01
description Abstract Subjective The aim of the present study was to investigate the prognostic significance of preoperative complete blood count inflammatory markers in women operated for invasive Epithelial Ovarian Cancer (EOC). Method Two hundred forty four patients that underwent operation with the diagnosis of invasive EOC between 2006 and 2014 were included in the study. The date of operation, date of recurrence and final mortality evaluations were performed for survival analysis. The sensitivity, specificity, PPV and NPV were separately calculated with ROC analysis. Survival analysis was carried out with Kaplan Meier-Log Rank Method. Results Five-years overall survival rate was 56, 9% and 5-year disease-free survival (DFS) rate was 45,5%. Advanced disease stage, moderate-poor tumor differentiation, and the presence of recurrence were determined to have significant inverse relation at mean survival and 5-year survival rates. Neutrophil/lymphocyte ratio (NLR) and Platelet lymphocyte ratio (PLR) had prognostic effect on both DFS and overall survival based upon the cut-off values determined in the study (PLR = 231, s36, NLR = 3,83). Histopathological subtypes were not found to have any prognostic value. In correlation analysis, PLR and NLR had positive correlation with each other and negative correlation with overall survival. Conclusions Inflammatory markers such as NLR and PLR have independent prognostic value for women who undergo surgery for invasive EOC.
topic Epithelial ovarian cancer
Survival
PLR
NLR
url http://link.springer.com/article/10.1186/s13048-019-0491-7
work_keys_str_mv AT mehmetufukceran cancompletebloodcountinflammatoryparametersinepithelialovariancancercontributetoprognosisasurvivalanalysis
AT umittasdemir cancompletebloodcountinflammatoryparametersinepithelialovariancancercontributetoprognosisasurvivalanalysis
AT esercolak cancompletebloodcountinflammatoryparametersinepithelialovariancancercontributetoprognosisasurvivalanalysis
AT tayfungungor cancompletebloodcountinflammatoryparametersinepithelialovariancancercontributetoprognosisasurvivalanalysis
_version_ 1725210050801172480